Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
O6-Benzylguanine and Temozolomide in Pediatric Gliomas
NCT00275002Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2006
- Primary completion
- Dec 2010
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of 6-benzylguanine in glioma, brainstem tumor (BSG), sponsored by National Cancer Institute. Started Feb 2006; status: completed.
02
Drugs
6-benzylguanine
03
Conditions
gliomabrainstem tumor (BSG)
Beyond the preview
Go deeper on NCT00275002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00275002.